Clinical trial

Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide

NCT03566511

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-06-12

PhasePHASE2

Study timeline

Study start (actual)2018-06-12Date precision: day

Registry last updated2025-05-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Glucose, High Bloodunresolved

Glucose Metabolism Disorders (Including Diabetes Mellitus)unresolved

Interventions

DiazoxideDRUG · verified · RxNorm: diazoxide

Sponsors & collaborators

Meredith Hawkinslead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

American Diabetes Associationcollaborator

Mapped research locations

The BronxNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03566511 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.